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ABSTRACT
OBJECTIVE: The objective of this selective EBM review is to determine whether or not ginger
is a safe and effective treatment for moderate or severe dysmenorrhea in females over the age of
18.
STUDY DESIGN: Review of three randomized controlled studies. All three studies are
published in English between 2009-2013.
DATA SOURCES: Three randomized placebo controlled studies found using PubMed and
Medline.
OUTCOMES MEASURED: The outcomes that were measured were severity of pain, duration
of pain, change in symptoms, and change in severity. This was done by using a visual analogue
scale, 5-point Likert scale, Wilcoxon’s rank-sum test, and verbal multidimensional scoring
system.
RESULTS: The first study, the Jenabi study showed that 29 subjects, 82.85%, reported
improvement in their dysmenorrhea symptoms compared to 16 subjects, 47.05%, in the placebo
group determined by the five-point Likert scale. In the second study, Ozgoli et al study showed
that 62% of subject showed improvement using ginger capsules via a verbal multidimensional
scoring system, as compared to 66% of patients using ibuprofen respectively. The third study,
Rahnama et al study showed that the ginger group reported 11 hours less pain duration as well
as 3 cm less in severity of pain than the placebo group, measured by verbal multidimensional
scoring system and visual analogue scale. No serious adverse events were noted in any of the
three studies.
CONCLUSIONS: Based on these three trials, ginger is a safe and effective treatment for
moderate or severe dysmenorrhea. Each study showed improvement of symptoms or showed it to
be as effective as NSAIDs without any serious side effects when using ginger.
KEY WORDS: Ginger, dysmenorrhea
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INTRODUCTION
Dysmenorrhea, also commonly referred to as menstrual cramps, can be characterized as
throbbing or cramping pains in the lower abdomen that can radiate to the inner thighs just before
or during a woman’s menstrual cycle with no identifiable pathologic lesion.1,5 It is considered
moderate or severe when a woman has either moderate or severe pain with influence on daily
activities, ineffective use of analgesics, and symptoms such as headache, tenderness, nausea,
vomiting, and diarrhea. 5 This paper evaluates three double blind, randomized controlled trials
comparing the efficacy of ginger as an oral medication compared to a placebo or NSAID for
improving moderate or severe dysmenorrhea in females over the age of 18.
Dysmenorrhea is relevant to the Physician Assistant profession due to its prevalence, cost
to the patients, and amount of lost time from school and work. Dysmenorrhea can have
significant effects on patients quality of life. It is extremely common, being one of the most
frequent gynecologic disorders, affecting more than half of menstruating women. 3 There is an
estimation that severe dysmenorrhea results in a loss of 600 million working hours and
approximately two billion dollars in lost productivity. 2,4 The exact number of health care visits
due to dysmenorrhea is unknown, however approximately 45.6% of women with severe
dysmenorrhea are absent from school or work, resulting in a need for a physician visit and
excuse, which is why it is so important for medical providers to aware of this problem. 4
The exact etiology of the dysmenorrhea is unknown; however, the symptoms are thought
to be associated with increased production of prostaglandins in the endomentrium which causes
increased myometrial contractility, uterine ischemia, and sensitizations of pain fibers.4,5 Due to
the unknown exact etiology, there is currently no curative treatment.
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In most cases of dysmenorrhea, nonsteroidal anti-inflammatory drugs (NSAIDs) are the
usual first line therapy.6 As the suggested etiology of dysmenorrhea is due to the excess
production of prostaglandins, the use of NSAIDs would cause inhibition of prostaglandin
synthesis, relieving women of dysmenorrhea.6 However, previous studies have showed that up to
25% of women fail the conventional therapy of NSAIDs or may also have contraindications to
the use of NSAIDs.6 Other methods that are commonly used for dysmenorrhea are combined
oral contraceptives. These hormones act by suppressing ovulation and lessening the endometrial
lining of the uterus, which in end decrease the amount of prostaglandins. 7 However, due to
many contraindications of the use of combined oral contraceptive pills, such as history of deep
venous thrombosis or family history of coagulopathies, some women may not be able to use
them as treatment for their dysmenorrhea. Due to the failure rate, limited efficacy, and
contraindications of NSAIDs and combined oral contraceptives, the use of ginger may be used as
an oral alternative for the relief of dysmenorrhea.
OBJECTIVE
The objective of this systematic review is to determine whether or not ginger is an
effective treatment for moderate or severe dysmenorrhea in females over the age of 18.
METHODS
All three studies used in this review required a population of females greater than the age
of 18 years old with moderate to severe dysmenorrhea. The intervention was the implementation
of ginger tablets, 250 mg or 500 mg, taken three times or four times a day. Comparisons were
made between subjects that took a ginger tablet and experimental groups who either took a
placebo or ibuprofen. The outcomes measured were severity of pain, duration of pain, and
change in severity. All three studies were randomized controlled trails (RCTs) that evaluated
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ginger as an effective treatment for moderate or severe dysmenorrhea in females 18 years or
older.
Keywords used when searching for articles consisted of ginger and dysmenorrhea, all of
which were in English and in peer-reviewed journals. The articles chosen were researched by the
author and obtained through either PubMed, Medine, OVID, or Google Scholar. The articles
were selected based on the types of studies, the relevance to the clinical question being asked and
that the outcomes of the studies mattered to patients. Inclusion criteria for selecting these articles
included randomized controlled studies that directly benefit the patient. Exclusion criteria
included patients under the age of 18 years old. The statistics that were utilized and reported
included relative benefit increase (RBI), absolute benefit increase (ABI), relative risk increase
(RRI), absolute risk increase (ARI), numbers needed to treat (NNT), numbers needed to harm
(NNH), and p-value. Table 1 displays the demographics and characteristics of the included
studies.

DeGraw, Dysmenorrhea and Ginger 4
Table 1- Demographics & Characteristics of included studies
Study
Type
# of
Age
Inclusion
Exclusion
Pts
(yrs)
Criteria
Criteria

W/D

Interventions

Jenabi4
(2013)

RCT

70

≥ 18
years
old

Patients ≥ 18
years old that
had moderate
to severe
dysmenorrhea

Cases of mild
dysmenorrhea

1

500 mg of
Ginger TID
for first 3
days of
menstruation

Ozgoli et
al 5
(2009)

Double
blind
RCT

150

≥ 18
years
old

Patients ≥ 18
years old that
had moderate
to severe
dysmenorrhea

Pre-existing
diagnosed
disease,
history of
gestation or
taking oral
contraceptives,
medicinal or
herbal
sensitivities,
BMI <19 or
>26, and mild
dysmenorrhea

0

250 mg of
Ginger QID
for first 3
days of
menstruation

Rahnama
et al 6
(2012)

Double
blind
RCT

120

≥ 18
years
old

Patients ≥ 18
years old that
had moderate
to severe
dysmenorrhea;
being single,
having a
menstrual
cycle that last
from 21 to 35
days with 2-6
days of flow
and average
blood loss of
20-60 ml.

Diagnosis of a
disease, a
history of
pregnancy or
taking oral
contraceptives,
BMI <19 or
>25, and mild
dysmenorrhea

15

500 mg of
Ginger TID
for first 3
days of
menstruation
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OUTCOMES MEASURED
In Rahnama et al study, the outcomes that were measured were the severity of pain and
duration of pain. The way they were measured were by using a verbal multidimensional scoring
system, visual analogue scale, and ANCOVA. In Jenabi’s study, the outcomes that were
measured were severity of pain and change in symptoms, which were measured by a visual
analgoue, 5-point Likert scale, and Wilcoxon’s rank-sum test. In the Ozgoli et al study, the
outcome that was measured was change in pain severity, which was measured by using a verbal
multidimensional scoring system and 5-point Likert-scale.
RESULTS
All three articles compared the use of ginger with the use of a placebo or ibuprofen for
the treatment of moderate or severe dysmenorrhea. Each article consisted of three randomized
controlled trails, all presented in continuous data which were then converted into dichotomous
data.
The Jenabi study excluded females that had mild dysmenorrhea. The subjects took either
a 500mg tablet of ginger TID or a placebo TID, depending on the group they were blindly placed
in. This study showed that compared to the baseline, the ginger group had a notably greater
reduction in pain compared to that of the placebo group, measure by visual analogue.4 The
change in pain scores are listed in Table 2, while the change in symptoms is listed in Table 3.
The change in pain score was greater in the ginger group at 3.81±1.17, while the placebo change
in pain score was only 0.48±0.91, with a p-value of 0.001, showing true significance.
Approximately 83% of subjects in the ginger group reported improvement in symptoms while
only 47% of the placebo group reported improvement in symptoms. The relative benefit increase
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(RBI) was 77.6%, the absolute benefit increase (ABI) was 36.1%, and the numbers needed to
treat (NNT) was 3, all of which point to this being a large treatment effect.
Table 2. Change in Pain Score for Jenabi Study.4
Type of Treatment
Before Use
(Mean±SD)

After Use (Mean±SD)

Before use- after use

Ginger

7.08 ± 1.02

4.81 ± 1.70

3.81 ± 1.17

Placebo

7.61 ± 1.20

7.11 ± 1.12

0.48 ± 0.91

p-value

0.61

0.001

0.001

Table 3. Change in symptoms for Jenabi Study.4
Change in Symptoms
Ginger

Placebo

Much worse

0

0

Worse

0

0

Same

6 (17.4%)

18 (53.5%)

Better

14 (40.0%)

10 (29.0%)

Much Better

15 (42.6%)

6 (17.5%)

n

35

34

Ozgoli et al study excluded females with pre-existing diagnosed disease, history of
gestation or taking oral contraceptives, medicinal or herbal sensitivities, BMI <19 or >26, and
mild dysmenorrhea.5 The subjects took either 250 mg of ginger QID or 400 mg of ibuprofen QID
for the first three days of the menstrual cycle. This study showed that ginger was an as effective
treatment as ibuprofen (NSAID) in the fact that both groups had a decrease in the severity of
dysmenorrhea with no differences between the groups in severity of dysmenorrhea, pain relief,
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or satisfaction with treatment.5 In the group taking ibuprofen, 66% of the subjects said that their
pain was either relieved or considerably relieved. In the ginger group, 62% of the subjects said
that their pain was either relieved or considerably relieved. Table 4 shows the change in pain
severity for both the ibuprofen and ginger groups. The RBI was -6.1%, the ABI was -4% and the
NNT was -25, all of which point to a large treatment effect.
Table 4. Change in pain severity for Ozgoli et al.5
Change in Pain Severity
Ibuprofen

Ginger

Considerably relieved

18 (36%)

18 (36%)

Relieved

15 (30%)

13 (26%)

Unchanged

17 (34%)

15 (30%)

Worse

3 (6%)

4 (8%)

Considerably worse

0

0

Rahnama et al study excluded subjects based on diagnoses of a disease, a history of
pregnancy or taking oral contraceptives, BMI <19 or >25, and mild dysmenorrhea.6 The subjects
took either 500 mg of ginger TID or a placebo TID for the first three days of the menstrual cycle.
There was two different protocols that were done, but for this paper we will focus on protocol 2
which consisted of either 500 mg of ginger TID or a placebo TID given for the first three days of
the menstrual period. This study showed that there was a noteworthy difference in severity of
pain between ginger and the placebo groups (p=0.008), however there was not a significant
change in the duration of pain (p=0.080) .6 The ginger group reported a 2.72 ± 2.82 change in
severity of pain from before and after use, while the placebo group reported a 1.51 ± 2.77 change
in severity of pain from before and after use.6 Table 5 and Table 6 show the change in pain
severity and duration of pain between the ginger and placebo group. The relative risk increase
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(RRI) was -41%, the absolute risk increase (ARI) is -3.6% and the numbers needed to harm
(NNH) was 27, all of which point to a large treatment effect.
Table 5. Change in severity of pain for Rahnama et al study. 6
Before Use
After Use
(Mean±SD)
(Mean±SD)

Before use- after
use

7.34 ± 1.1

2.72 ± 2.82

Ginger

4.61 ± 2.55

p-value

0.008
Placebo

7.52 ± 0.93

6.01 ± 2.65

1.51 ± 2.77

Table 6. Change in duration of pain for Rahnama et al study. 6
Before Use
After Use
Before use- after
(Mean±SD)
(Mean±SD)
use
19.38 ± 16.35
10.88 ± 14.54
8.50 ± 17.77
Ginger

p-value

0.080
Placebo

19.06 ± 22.73

15.57 ± 14.72

3.48 ± 23.08

DISCUSSION
Ginger is a complex herb that is essentially made up of sesquiterpene, but also includes
carbohydrates, free fatty acids, amino acids, proteins, phytoesterols, niacin, and nonaromatic
compounds. 5, 8 It has been found that ginger inhibits cyclooxygenase and lipoxygenase pathways
in the prostaglandin pathway synthesis as well as have anti-inflammatory effects, which is why
they believe ginger improves females dysmenorrhea. 5,6 Ginger has also been found to help in
other problems including dyspepsia, colic, vomiting, diarrhea, colds, influenza, arthritis, kidney
stones, and asthma. 4,5
All three studies analyzed showed a greater improvement in dysmenorrhea with the use
of ginger compared to the use of placebo and was consider as adequate as ibuprofen. This review
supports the use of ginger in the treatment of dysmenorrhea but there are some limitations in the
studies used. Both Rahnama et al and Ozgoli et al studies both made distinct points with the lack
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of observation regarding the effects on ginger on the other symptoms that are linked to
dysmenorrhea such as nausea, vomiting, etc. 5,6 Furthermore, in the Rahnama et al study, 13
patients from the placebo group had left the study and no data was available from them. In all
three studies there is a strong indication that there is a limitation on the physiology of why ginger
helps with improvement of dysmenorrhea. There is a strong suggestion that in order to expand
our knowledge and understanding of why ginger works to improve dysmenorrhea, further studies
need to be done, as well as knowing the exact etiology of dysmenorrhea.
CONCLUSION
Based on this systematic review and chosen studies, ginger is an effective treatment for
moderate or severe dysmenorrhea. The data within these three studies are consistent with the
beneficial effects of ginger as well as its overall safety. No serious adverse effects were noted in
any of the studies. Therefore it should be considered by healthcare providers to recommend to
patients as a treatment of moderate or severe dysmenorrhea. Additional studies investigating the
effects of ginger on other symptoms associated with dysmenorrhea, the safety of various doses of
ginger, and the exact mechanism of action of ginger should be considered. 4,5,6
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